Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.83 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.83 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.82 |
| ▸ | NAMPT | P43490 | 3/20 | 0.81 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.81 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.81 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.69 |
| ▸ | RAB9A | P51151 | 5/20 | 0.68 |
| ▸ | NPC1 | O15118 | 4/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.68 |
| ▸ | MEN1 | O00255 | 1/20 | 0.68 |
| ▸ | TP53 | P04637 | 1/20 | 0.68 |
| ▸ | GAA | P10253 | 1/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.66 |
| ▸ | HTT | P42858 | 1/20 | 0.66 |
| ▸ | JAK2 | O60674 | 1/20 | 0.66 |
| ▸ | TYK2 | P29597 | 1/20 | 0.66 |
| ▸ | PIM1 | P11309 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nicotinanilide SCHEMBL29067673 | 1.00 | LMNA (0.83) | LMNAHIF1AKCNK3NAMPTROCK2 | |
| Nicotinanilide SCHEMBL8155304 | 0.98 | LMNA (0.81) | LMNAHIF1AKCNK3NAMPTROCK2 | |
| Nicotinanilide SCHEMBL27369687 | 0.94 | LMNA (0.73) | LMNAHIF1AKCNK3NAMPTROCK2 | |
| SCHEMBL1571386 | 0.91 | LMNA (1.00) | LMNAHIF1AKCNK3NAMPTROCK2 | |
| Nicotinanilide SCHEMBL27980002 | 0.91 | LMNA (0.69) | LMNAHIF1AKCNK3NAMPTROCK2 | |
| SCHEMBL167081 | 0.89 | NAMPT (1.00) | LMNAHIF1AKCNK3NAMPTRAB9A | |
| SCHEMBL14880208 | 0.89 | ROCK2 (1.00) | LMNAHIF1AKCNK3NAMPTROCK2 | |
| SCHEMBL7329481 | 0.88 | ROCK2 (0.73) | LMNAHIF1AKCNK3NAMPTROCK2 | |
| Hydrochloric Acid SCHEMBL27890956 | 0.88 | NAMPT (0.97) | LMNAHIF1AKCNK3NAMPTRAB9A | |
| SCHEMBL28276093 | 0.87 | NPC1 (0.70) | LMNAHIF1AKCNK3NAMPTROCK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 838 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4687829-A1 | COMPOSITION FOR CARING FOR KERATIN MATERIALS | L'OREAL (FR) | 2026-02-11 | — | — | EP | claimed |
| US-20250381116-A1 | SOLUBILIZATION OF THIOPYRIDINONE COMPOUND AND COMPOSITION COMPRISING SAME | OREAL (FR) | 2025-12-18 | — | — | US | claimed |
| US-20250161201-A1 | COSMETIC COMPOSITION | THE BOOTS COMPANY PLC (GB) | 2025-05-22 | — | — | US | claimed |
| WO-2025091239-A1 | COMPOSITION IN THE FORM OF OIL-IN-WATER EMULSION | L'OREAL (FR) | 2025-05-08 | — | — | WO | claimed |
| WO-2025091220-A2 | COMPOSITION IN THE FORM OF OIL-IN-WATER EMULSION | L'OREAL (FR) | 2025-05-08 | — | — | WO | claimed |
| EP-4543408-A1 | SOLUBILIZATION OF THIOPYRIDINONE COMPOUND AND COMPOSITION COMPRISING SAME | L'OREAL (FR) | 2025-04-30 | — | — | EP | claimed |
| EP-4479146-A1 | COSMETIC COMPOSITION | The Boots Company PLC (GB) | 2024-12-25 | — | — | EP | claimed |
| WO-2024197798-A1 | COMPOSITION FOR CARING FOR KERATIN MATERIALS | L'OREAL (FR) | 2024-10-03 | — | — | WO | claimed |
| CN-118252153-A | Pond cleaning agent for aquaculture and preparation method thereof | 江苏牧王药业有限公司 | 2024-06-28 | — | — | CN | claimed |
| WO-2024045013-A1 | COMPOSITION FOR CARING FOR THE SKIN | L'OREAL (FR) | 2024-03-07 | — | — | WO | claimed |
| CN-1558901-A | Crystalline hydrates of nicotinic acid anilide and benzoyl anilide derivatives | �����ɷ� | 2004-12-29 | — | — | CN | claimed |
| US-20040249164-A1 | Crystalline hydrates of nicotinic acid anilide and benzoyl anilide derivatives | BASF AKTIENGESELLSCHAFT (DE) | 2004-12-09 | — | — | US | claimed |
| EP-1319336-B1 | Method of preparation of solvent-free suspensions | BASF AG (DE) | 2004-06-23 | — | — | EP | claimed |
| WO-2004046113-A2 | PYRIDINE N-OXIDE COMPOUNDS AS PHOSPHODIESTERASE 4 INHIBITORS | MEMORY PHARMACEUTICALS CORPORATION (US) | 2004-06-03 | — | — | WO | claimed |
| EP-1367985-A2 | ANHYDROUS ANTIPERSPIRANT AND DEODORANT COMPOSITIONS CONTAINING A SOLID, WATER-SOLUBLE, SKIN ACTIVE AGENT | THE PROCTER & GAMBLE COMPANY (US) | 2003-12-10 | — | — | EP | claimed |
| EP-0896522-B1 | METHODS OF REGULATING SKIN APPEARANCE WITH VITAMIN B 3 COMPOUND | PROCTER & GAMBLE (US) | 2003-10-22 | — | — | EP | claimed |
| US-20030148887-A1 | Process for the preparation of solvent-free suspensions | BASF AKTIENGESELLSCHAFT (DE) | 2003-08-07 | — | — | US | claimed |
| WO-2002069916-A2 | ANHYDROUS ANTIPERSPIRANT AND DEODORANT COMPOSITIONS CONTAINING A SOLID, WATER-SOLUBLE, SKIN ACTIVE AGENT | THE PROCTER & GAMBLE COMPANY (US) | 2002-09-12 | — | — | WO | claimed |
| US-6383476-B1 | Anhydrous antiperspirant and deodorant compositions containing a solid, water-soluble, skin active agent | THE PROCTER & GAMBLE COMPANY | 2002-05-07 | — | — | US | claimed |
| CN-1123083-A | Method for increasing yield of soybean | SUMITOMO CHEMICAL CO (JP) | 1996-05-29 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040249164-A1 | Crystalline hydrates of nicotinic acid anilide and benzoyl anilide derivatives | NAPRT, NAMPT, NME1 | LMNA 2681/4885HIF1A 3879/4885KCNK3 4378/4885 |
| US-20250161201-A1 | COSMETIC COMPOSITION | CYP19A1, SHBG, HSD17B11 | LMNA 3019/4885HIF1A 2176/4885KCNK3 520/4885 |
| US-20030148887-A1 | Process for the preparation of solvent-free suspensions | MLN, SAMM50, SOST | LMNA 2232/4885HIF1A 4487/4885KCNK3 4166/4885 |
| US-20250381116-A1 | SOLUBILIZATION OF THIOPYRIDINONE COMPOUND AND COMPOSITION COMPRISING SAME | TBCB, CCNB3, CYP24A1 | LMNA 3917/4885HIF1A 4367/4885KCNK3 2693/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.